Valuation: Abbott Laboratories

Market Cap 181B 162B 150B 136B 254B 17,266B 259B 1,807B 715B 9,031B 681B 667B 28,594B P/E 2026 *
34.7x
P/E 2027 * 25.2x
Enterprise Value 205B 183B 170B 154B 287B 19,507B 292B 2,041B 807B 10,203B 770B 753B 32,305B EV / Sales 2026 *
4.1x
EV / Sales 2027 * 3.77x
Free-Float
86.16%
Yield 2026 *
2.47%
Yield 2027 * 2.64%
1 day+1.14%
1 week+0.79%
Current month+6.12%
1 month+3.54%
3 months+1.77%
6 months+15.09%
Current year-16.29%
1 week 97.67
Extreme 97.67
106.35
1 month 95.06
Extreme 95.06
106.35
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

333 0.0000%
9/30/26 Free

Director

318 0.0000%
9/30/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+0.79%-17.32%+11.60% 179B
-0.33%+2.75%-19.82%+18.39% 118B
-0.65%+2.18%+1.20%+34.70% 117B
-3.42%+15.09%-44.16%+5.61% 93.26B
-0.30%-2.94%-0.81%+74.97% 63.16B
+1.53%+2.00%+8.89%+82.89% 55.68B
-1.27%+2.96%+5.68%-22.74% 54.18B
+1.75%+2.59%-11.02%+43.47% 44.15B
+0.03%+6.23%-5.17%-7.53% 33.95B
-1.17%-4.26% - - 29.91B
Average -0.27%+2.44%-9.17%+26.82% 78.83B
Weighted average by Cap. -0.24%+2.74%-12.30%+24.53%

Financials

2026 *2027 *
Net sales 49.96B 44.68B 41.33B 37.43B 70.05B 4,754B 71.19B 497B 197B 2,486B 188B 184B 7,872B 53.53B 47.86B 44.28B 40.1B 75.04B 5,093B 76.27B 533B 211B 2,664B 201B 197B 8,434B
Net income 5.64B 5.05B 4.67B 4.23B 7.91B 537B 8.04B 56.18B 22.22B 281B 21.18B 20.73B 889B 7.66B 6.85B 6.34B 5.74B 10.74B 729B 10.92B 76.29B 30.18B 381B 28.76B 28.15B 1,207B
Net Debt 23.55B 21.06B 19.49B 17.64B 33.02B 2,241B 33.56B 234B 92.76B 1,172B 88.41B 86.52B 3,711B 20.14B 18.01B 16.66B 15.08B 28.23B 1,916B 28.7B 200B 79.3B 1,002B 75.58B 73.97B 3,173B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-10-26 $104.88 +1.14% 7,840,828
26-10-23 $103.70 +1.16% 10,296,890
26-10-22 $102.51 +1.99% 10,661,558
26-10-21 $100.51 -1.89% 22,909,735
26-10-20 $102.45 -1.55% 13,854,369
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
104.88USD
Average target price
118.52USD
Spread / Average Target
+13.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories